FULLERTON, Calif., July 17 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. announced today its report on form 10-Q for the quarter ended March 31, 2006 was filed earlier today.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )
The company previously announced on May 3, 2006, that the Audit and Finance Committee of the Board of Directors was overseeing an inquiry into claims made by a former employee relating to certain accounting and financial reporting issues. The Audit and Finance Committee retained legal counsel and an outside forensic accounting firm to conduct the inquiry into the allegations made by the former employee. Based upon the work and recommendations of its counsel and forensic accountants, the Audit and Finance Committee concluded that the former employee’s allegations were not substantiated and that no adjustment to the company’s financial statements was required.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum - from pioneering medical research and clinical trials to laboratory diagnostics and point-of- care testing - Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, California, reported 2005 annual sales of $2.44 billion with 71.5 percent of this amount generated by recurring revenue from supplies, test kits, services and operating-type lease payments. For more information, visit http://www.beckmancoulter.com.
Contact: Robert Raynor (714) 773-7620 Director, Investor Relations
Photo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOBeckman Coulter, Inc.
CONTACT: Robert Raynor, Director, Investor Relations of Beckman Coulter,Inc., +1-714-773-7620
Web site: http://www.beckmancoulter.com/
